NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 84 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,084,000 | -70.0% | 224,945 | -55.0% | 0.00% | -66.7% |
| Q3 2021 | $3,615,000 | -21.7% | 500,000 | 0.0% | 0.01% | -14.3% |
| Q2 2021 | $4,615,000 | -25.0% | 500,000 | 0.0% | 0.01% | -22.2% |
| Q1 2021 | $6,155,000 | -12.7% | 500,000 | 0.0% | 0.01% | -18.2% |
| Q4 2020 | $7,050,000 | +193.8% | 500,000 | +150.0% | 0.01% | +175.0% |
| Q3 2020 | $2,400,000 | -27.7% | 200,000 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $3,320,000 | +45.9% | 200,000 | 0.0% | 0.01% | -20.0% |
| Q1 2020 | $2,276,000 | -7.6% | 200,000 | 0.0% | 0.01% | +11.1% |
| Q4 2019 | $2,464,000 | – | 200,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,047,300 | $5,048,000 | 1.07% |
| ACT CAPITAL MANAGEMENT, LLC | 212,500 | $1,024,000 | 0.74% |
| Redmile Group, LLC | 3,490,835 | $16,826,000 | 0.38% |
| Kynam Capital Management, LP | 147,000 | $709,000 | 0.38% |
| EcoR1 Capital, LLC | 860,619 | $4,148,000 | 0.13% |
| Baker Brothers Advisors | 3,821,740 | $18,421,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 130,899 | $631,000 | 0.08% |
| Sio Capital Management, LLC | 38,312 | $185,000 | 0.06% |
| Highland Private Wealth Management | 46,999 | $227,000 | 0.03% |
| XTX Topco Ltd | 10,018 | $48,000 | 0.03% |